ArticleCancer immunology, immunotherapy : CII2021

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma.

Tan-Huy Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.